General Information of the Compound
| Compound ID |
CP0538047
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-3-hydroxy-1-[1-[6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-yl]-2,3-dihydroindol-5-yl]piperidin-2-one
Show/Hide
|
||||||||||||||||||
| Formula |
C27H33N7O4
|
||||||||||||||||||
| Molecular Weight |
519.606
|
||||||||||||||||||
| Canonical SMILES |
CC(C)c1noc(n1)N1CCC(CC1)Oc1cc(ncn1)N1CCc2cc(ccc12)N1CCC[C@H](O)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H33N7O4/c1-17(2)25-30-27(38-31-25)32-11-8-20(9-12-32)37-24-15-23(28-16-29-24)34-13-7-18-14-19(5-6-21(18)34)33-10-3-4-22(35)26(33)36/h5-6,14-17,20,22,35H,3-4,7-13H2,1-2H3/t22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WYCBJYYEIKRIBR-QFIPXVFZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02455, Glucose-dependent insulinotropic receptor
Protein ID: PT01297, Glucose-dependent insulinotropic receptor